Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples